Symposium: Update on prediction and management of OHSS - Opinion. Prevention of OHSS: GnRH agonist versus HCG to trigger ovulation

Shahar Kol, Jehoshua Dor

Research output: Contribution to journalArticlepeer-review

Abstract

Ovarian hyperstimulation syndrome (OHSS) remains a major complication of IVF. Triggering ovulation with human chorionic gonadotrophin (HCG) (as a surrogate to LH) is a major factor in the initiation of OHSS. The pathological process usually intensifies if pregnancy is achieved, as the rising endogenous HCG overstimulates the corpora lutea. Decreasing HCG trigger dose does not prevent OHSS. Gonadotrophin-releasing hormone agonists (GnRHa) induce endogenous LH and FSH surges that reliably trigger ovulation, even if a GnRH antagonist is used during ovarian stimulation. Moreover, such a trigger quickly and irreversibly induces luteolysis, thereby preventing OHSS. Contrasting reports regarding clinical outcome probably reflect different approaches to luteal phase support. Zygotes or embryos frozen post GnRHa trigger give excellent clinical outcome post thaw. In summary, GnRHa trigger is the key for complete OHSS prevention.

Original languageEnglish
Pages (from-to)59-60
Number of pages2
JournalReproductive BioMedicine Online
Volume19
Issue number1
DOIs
StatePublished - Jul 2009
Externally publishedYes

Keywords

  • GnRH agonists
  • HCG
  • Ovarian hyperstimulation syndrome
  • Ovarian stimulation

Fingerprint

Dive into the research topics of 'Symposium: Update on prediction and management of OHSS - Opinion. Prevention of OHSS: GnRH agonist versus HCG to trigger ovulation'. Together they form a unique fingerprint.

Cite this